Introduction
Endothelial cells play a key role in the vascular homeostasis and several aspects of vascular biology, including the permeability barrier function, inflammation, and angiogenesis. 1 Inflammation localized in vascular tissue is an important contributor to the pathophysiology of cardiovascular diseases including atherosclerosis and hypertension. [2] [3] [4] Angiotensin II (Ang II) is a major mediator of the renin-angiotensin system, associated with cardiovascular diseases. 5, 6 Ang II leads to the overexpression of inflammation-related genes such as cellular adhesion molecules [e.g. vascular adhesion molecule-1 (VCAM-1)], inducible nitric oxide synthase (iNOS) and cyclooxygenase-2 (COX-2) and pro-inflammatory cytokines [e.g. interleukin-6 (IL-6)], thus conferring an inflammatory phenotype that contributes to endothelial dysfunction. [7] [8] [9] Therefore, the inhibition of Ang II-induced inflammation may provide benefits to cardiovascular diseases. Epigenetic mechanisms contribute to diverse physiological systems and pathological process. 10 Histone acetyltransferases (HATs) and histone de-acetylases (HDACs) control a wide array of biological processes by epigenetically regulating accessibility of transcription factors to the gene promoter by acetylation or de-acetylation of the histone. 11 Up to now, HDACs have been classified into four groups termed class I HDACs (HDAC1, 2, 3, and 8), class II HDACs (HDAC4, 5, 6, 7, 9, and 10), class III HDACs, and class IV HDAC (HDAC11). 12 Among them, it was reported that HDAC4 plays important roles in mediating cardiovascular diseases. For example, in cultured cardiomyocytes, HDAC4 is regulated by hypertrophic agonists 13 and HDAC4 controls neointimal hyperplasia via stimulating proliferation and migration of vascular smooth tective role via clearing the damaged and unhealthy organelles. However, the massive and persistent activation of autophagy may contribute to excessive cell inflammation and pathological angiogenesis. 19, 20 In addition, recent reports demonstrate that multiple forms of stress, including pressure overload, chronic ischaemia, and ischaemia-reperfusion provoke an increase in autophagic activity in cardiovascular diseases, thereby activated autophagy contributes to disease pathogenesis. 21 FoxO3a is an isoform of transcription factor forkhead box class O (FoxO) family, and can regulate autophagy in skeletal and cardiac muscles by activating genes that are involved in autophagosome formation. 22 Thus, considering that autophagy is involved in cardiovascular system, protectively or detrimentally, meanwhile, HDAC4 regulates cardiovascular diseases, [23] [24] [25] we hypothesize that maladaptive autophagy is HDAC4 dependent and contributes to the further development of vascular inflammatory. We further posit that HDAC4 facilitating FoxO3a de-acetylation to mediate autophagy plays significant roles in Ang IIinduced vascular inflammatory.
Methods

Materials
Reagent sources were as follows: angiotension (Ang II) was from SigmaAldrich (St. Louis, MO, USA). 3-methyladenine (3-MA), LY294002 (LY), and tasquinimod (Taq) was purchased from Selleckchem (Selleck, USA). Mithramycin (Sp-1 inhibitor) was purchased from Calbiochem (San Diego, CA). Antibodies were obtained from the following commercial sources: VCAM-1 was purchased from Proteintech (Proteintech, USA); IL-6 and iNOS were purchased from Epitomics (Burlingame, CA); HDAC4, FoxO3a, LC3-II, Atg5, and Beclin 1 were purchased from Cell Signalling Biotechnology (Danvers, MA, USA); COX2, HDAC4, and GAPDH were obtained from Santa Cruz Biotechnology (Santa Cruz, CA, USA). Acetyl Lysine polyclonal antibody was purchased from BioVision (BioVision Incorporated, CA, USA).
Animal studies
All animal procedures conformed to the Guide for the Care and Use of Laboratory Animals published by the US National Institutes of Health (NIH Publication, 8th Edition, 2011) and were approved by Institutional Animal Care and Use Committee (IACUC), School of Pharmacy, Fudan University, China. C57BL/6 mice (6-8 weeks of age) were randomly assigned to one of four groups: The sham control group, Ang II infusion group, shRNA HDAC4 group (HDAC4 KD), and 3-MA group. Briefly, the mice were anesthetized under isoflurane (induction: 3-4%, maintenance: 2-3%; in 0.2 L/min medical air and 0.2 L/min O 2 ), followed by subcutaneous implantation of an Alzet mini-osmotic pump (Model 2004, ALZA Scientific Products, Mountain View, CA, USA) containing only saline (control group), or Ang II dissolved in saline. Mice were then continuously infused with saline or Ang II (1.5 mg/kg/d). One week after miniosmotic pump, in HDAC4 KD group, these mice were injected via tail vein with purified lentiviral particles (1 Â 10 9 MOI) that carry short hairpin RNA (shRNA) targeting HDAC4 every 7 days until the end of the experiment. The 3-MA treatment group was given a daily intraperitoneal injection (i.p.) injection of 3-MA (20 mg/kg/day) until the end of the experiment on day 28. 3-MA was dissolved in dimethyl sulfoxide (DMSO) and then diluted with phosphate-buffered saline (PBS) to the final concentration. Ang II infusion group was injected via tail vein with entiviral vector (shMock). After 4 weeks, mice were anesthetized with sodium pentobarbital (60 mg/kg) and the thoracic aorta of each mouse was cut into two sections. One section was stored at -80 C for protein extraction. The other section was fixed with 4% paraformaldehyde overnight, and was then embedded in paraffin for immunofluorescence staining.
Culture of primary vascular cells and treatment
Rat primary endothelial cells (RAECs) were isolated from male rats according to the method described previously. 26 Male Sprague-Dawley rats, 80-100 g, were anesthetized with sodium pentobarbital (40 mg/kg, Sigma), the isolated cells were cultured in DMEM supplemented with 20% foetal bovine serum, 1% penicillin-streptomycin, at 37 C in a 95% air/5% CO 2 incubator. The cells passages of 3-6 were used for all of the experiments performed. The identity of the RAECs was confirmed by immunofluorescence staining by CD31 antibody. The different batch of RAECs was used in each in vitro assay. Drugs were used at the following final concentrations: Ang II at 2 lM; 3-MA at 5 mM; Taq at 10 lM; LY294002 at 10 lM. Rat primary VSMCs were isolated from the abdominal aortic arteries of rats and identified following the same protocol as described previously. 27 The cells passages of 3-7 were used for all of the experiments performed.
Small interfering RNA (siRNA) transfection
HDAC4 siRNA (5'-GCUAUGACGAUGGGAACUUTT-3'), LC3-II siRNA (5'-GCUUCGAACAAAGAGUGGATT-3'), FoxO3a siRNA (5'-CCCAGAUCUACGAGUGGAUTT-3'), and control siRNA were produced by GenePharma (Shanghai, China). To introduce siRNA into cells, the cells were plated on 6-well plates at 30% to 50% confluence before transfection. Individual siRNA (at 25 to 50 nM), Lipofectamine RNAiMAX, and Opti-MEM was mixed and incubated at room temperature for 5 min. siRNA-lipofectamine RNAiMAX complexes were added to cells for 24 h and the medium was replaced by fresh serum DMEM medium after transfection. The efficiency of gene knockdown was verified by western blot 72 h post-transfection.
Lentivirus generation and infection
The specific Short Hairpin RNA (shRNA) HDAC4 was gift from Prof. Zeng (Shandong University, Jinan, China). Lentivirus generation and infection were performed according our described previously. 28 In brief, lentivirus was generated in HEK293T after transfection with lipofectamine 2000 (ThermoFisher Scientific, Shanghai, China) and plasmids. We collected culture media 48 h after transfection and added fresh media to the transfected cells and collected them 24 h later again. The two collections of media were combined and virus particles were pelleted by 
mCherry-GFP-LC3 assay
Autophagy was visualized in RAECs by transfection of the adenovirus expressing mCherry-GFP-LC3B fusion protein (Ad-mCherry-GFP-LC3B, Biotime Biotechnology, Jiangsu, China) and followed by analysis with a fluorescence microscopy (Zeiss LSM780, Carl Zeiss Table S1 for the primer sequences.
Western blotting
Cell and tissue proteins lysed in RIPA buffer (Pierce, Rockford, IL, USA) containing protease inhibitor cocktail (Sigma, St Louis, USA). Whole lysates samples were separated by sodium dodecyl sulfatepolyacrylamide gel electrophoresis and transferred to the nitrocellulose membrane. Membranes were incubated with the specified primary antibodies and HRP-conjugated secondary antibodies detected by the Supersignal West Dura Extended Duration Substrate kit (Pierce). In some cases, western blotting was performed with fluorophoreconjugated secondary antibodies, and detection and analysis were performed with the Odyssey imaging system (LI-COR).
Co-immunoprecipitation
Following different treatments, RAECs or vascular tissues were lysed with the RIPA buffer, the debris was removed by centrifugation at 10 000 g for 10 min. Aliquots (500-1000 lg) of lysates were incubated with rabbit-IgG antibody or Acetyl Lysine (Biotin) Polyclonal antibody (BioVision) at 4 C for 1 h, then were incubated with 20 lL of suspended volume of Protein A/G PLUS-Agarose (Santa Cruz Biotechnology) at 4 C on a rocker platform overnight. Immunoprecipitates were collected by centrifugation at 2500 rpm for 5 min at 4 C. The pellet was washed four times with 1.0 mL RIPA buffer, each time repeating centrifugation step above. After final wash, supernatant was discarded and pellet was re-suspended in 40 lL of 1 Â electrophoresis sample buffer, then were analysed by SDS-PAGE and autoradiography.
Chromatin immunoprecipitation PCR (ChIP-PCR)
ChIP assays of RAECs induced with Ang II (2 lM) for 1 h or 48 h were performed using EZ-ChIP TM Chromatin immune-precipitation kit (Millipore) according to the manufacturer's instructions. Antibody for FoxO3a was used for chromatin immunoprecipitation (ChIP). Primers for the ChIP assay were designed in the promoter regions of MAP1LC3B (LC3-II) and Atg5. Sequences of primers for the ChIP assay were as Supplementary material online, Table S2 .
Immunofluorescence staining
The arterial sections were blocked and incubated overnight with primary antibodies at 4 C. RAECs were cultured on coverslips placed in cell cultured plate. Following different treatments, cells were fixed with 4% paraformaldehyde for 15 min, followed by permeabilization with 0.2% Triton X-100 in PBS 10 min. Next, the slides were blocked in PBS with 10% goat serum for 1 h at room temperature, and incubated overnight with primary antibodies at 4 C. Appropriate secondary antibodies were incubated for 1 h at 37 C. The nuclei were stained with DAPI.
The images were captured by using a fluorescence microscope (Zeiss LSM780, Carl Zeiss).
Statistical analysis
Experimental results were expressed as means ± SEM. Differences of means were analysed by using one-way ANOVA with the TurkeyKramer post hoc test for multiple groups and unpaired Students t-test for two groups. Probability values, P < 0.05 were considered significant.
Results
Ang II induces autophagy and inflammation in RAECs with enhanced HDAC4 expression
RAECs were treated with Ang II (2 lM) for 24, 48, and 72 h, protein expression was shown in Figure 1A . Ang II treatment for all three time periods markedly increased inflammatory mediators such as COX2 and VCAM-1 expression. Furthermore, HDAC4 up-regulation was also visible at the mRNA and protein level ( Figure 1A and B). Autophagy is an important mechanism during the regulation of cell homeostatic process. LC3-II, Atg5 and Beclin1 are also used as markers of autophagy. Thus, to further examine whether Ang II treatment induced autophagy, we measured the LC3-II, Atg5 as well as Beclin 1 expression following Ang II treatment. Notably, the protein levels of LC3-II, Beclin1, and Atg5 appeared to increase after treatment with Ang II in a time-dependent manner in RAECs ( Figure 1A) . Using immunofluorescence double staining we found that HDAC4 and LC3-II were consistently up-regulated ( Figure 1C) . To determine if Ang II-treated cells activated autophagy, we used red/green fluorescence expressing a tandem-tagged mCherry-GFP-LC3B fusion protein, which allows for analysis of autophagy due to loss GFP but retention of mCherry fluorescence in lysosomes. 29 Ang II treated cells exhibited numerous GFP-LC3 dots ( Figure 1D) , consistent with the activation of autophagy. These results showed Ang II induced autophagy and inflammation with enhanced HDAC4 expression in RAECs.
To address whether such association exists in animals, mice were subjected to a 28-day infusion of vehicle or Ang II, and the aorta vessels were assessed for HDAC4 and autophagy. Strikingly, the abundance of HDAC4 at the mRNA and protein level was dramatically increased in response to Ang II induction ( Figure 1E and F) . This increase was concomitant with the up-regulation of some classic markers of autophagy and inflammation ( Figure 1F) . Immunofluorescence staining showed that the expression of HDAC4 in vascular wall was increased in Ang IIinfused mice ( Figure 1G ). All these results supported the idea that HDAC4 and autophagy was associated with vascular inflammation not only in cell model but also in animal model. 
HDAC4 regulates vascular inflammation
Silencing of HDAC4 and inhibitor Taq reverses Ang II-induced RAECs inflammation
As shown in Figure 1A , Ang II significantly induced HDAC4 expression in RAECs in a time-dependent manner. To further investigate the role of HDAC4 on RAECs function, gene silencing of HDAC4 by siRNA-HDAC4 was used in this study. We found that Ang II-induced the production of pro-inflammatory mediators, such as IL-6, VCAM-1, COX2, and iNOS were attenuated by HDAC4 knockdown (Figure 2A) . Moreover, to further determine whether HDAC4 mediates inflammation response, we used Taq, an inhibitor of HDAC4. The proinflammatory mediators were significantly decreased in Ang II/Taqco-treated RAECs, but increased in Ang II-treated cells ( Figure 2B) . Immunofluorescence analysis further confirmed that treatment with siRNA HDAC4 or Taq also resulted in decreased HDAC4 and VCAM-1 protein expression ( Figure 2C) . Our study showed that Ang II induced inflammatory response, which was alleviated by HDAC4 deficiency.
Inhibition of autophagy reverses Ang II-induced RAECs inflammation
A growing body of studies has suggested that autophagy contributes to endothelial dysfunction in vascular biology, and autophagy is connected to the expression of inflammatory cytokines. As shown in Figure 1 , Ang II significantly induced autophagy in RAECs in a time-dependent manner. To further investigate the role of autophagy on RAECs function, gene silencing of LC3-II by siRNA was used. We found that Ang II-induced production of pro-inflammatory mediators was attenuated by LC3-II knockdown compared with siRNA control ( Figure 3A and B) . Moreover, we measured the expression of pro-inflammatory mediators following co-treatment with Ang II and the autophagy inhibitor LY294002 or 3-MA. The expression of IL-6, VCAM-1, and COX2 was decreased in LY294002 or 3-MA-treated cells ( Figure 3C and D) . These data indicated that inhibition of autophagy reversed the effects of Ang II-induced inflammation in RAECs.
Silencing of HDAC4 and inhibitor Taq reverses Ang II-induced autophagy in RAECs
In order to analyse a potential role of HDAC4 in an autophagy-mediated inflammation in RAECs, HDAC4 was silenced by siRNA transfection, RAECs followed by a treatment with Ang II, siRNA clearly attenuated HDAC4 protein levels ( Figure 4A) . Intriguingly, knockdown of HDAC4 could block the Ang II-induced increase in Beclin 1, Atg5, and LC3-II ( Figure 4A) . Immunofluorescence double staining also showed that the co-expressions of HDAC4 and LC3-II upon Ang II induction disappeared when knockdown of HDAC4 ( Figure 4B) . Besides, Ad-GFP-LC3 punctate formation assays further confirmed that HDAC4 knockdown inhibited Ang II-induced autophagy activation in RAECs ( Figure 4C) .
Next, to further clarify the role of HDAC4 on activating autophagy, we used HDAC4 inhibitor Taq to examine the beneficial effect after the onset of autophagy. As shown in Figure 4D , HDAC4 inhibitor Taq decreased autophagy markers Beclin 1, LC3-II, and Atg5 levels in RAECs under Ang II treatment. Additionally, Ad-GFP-LC3 punctate formation further confirmed that Taq inhibited Ang II-induced autophagy in RAECs ( Figure 4E ). All these results supported the idea that HDAC4 deficiency could alleviate activation of autophagy in Ang II-induced RAECs.
Knockdown of HDAC4 ameliorates Ang II-induced vascular inflammation in vivo
VSMCs are also a dominant cellular constituent of arteries and a critical determinant of vascular disease. VSMCs were treated with Ang II (2 lM) for the indicated time, HDAC4, and the inflammatory mediator VCAM-1 expression were markedly increased, with up-regulated autophagy makers LC3-II and Atg5 ( Figure 5A) . Furthermore, using siRNA-HDAC4 to silence HDAC4 expression, Ang II-induced production of proinflammatory mediators, such as IL-6, VCAM-1, and iNOS, were attenuated by HDAC4 knockdown, whilst Atg 5 expression also decreased ( Figure 5B) . These results showed that Ang II induced HDAC4 expression in RAECs as well as VSMCs.
To address the role of HDAC4 and autophagy in Ang II-induced vascular inflammation in vivo, lentivirus-mediated knockdown of HDAC4 and autophagy inhibitor 3-MA were applied in mice model. Mice were subjected to Ang II-infusion, followed by treatment of lentivirus encoding control or HDAC4 short hairpin RNA (KD HDAC4) ( Figure 5C ) or 3-MA. As shown in Figure 5D , Ang II-induced VCAM-1, IL-6, and iNOS expression were attenuated by HDAC4 knockdown, as well as attenuated by 3-MA. Importantly, HDAC4 knockdown was accompanied by decreased expression of autophagy markers including Beclin 1, Atg5, LC3-II, which was further confirmed by the fact that gene silencing of HDAC4 prevented the onset of autophagy after Ang II-infusion mice ( Figure 5D) . Immunofluorescence double staining analysis also showed HDAC4 knockdown was accompanied by decreased expression of LC3-II ( Figure 5E) . Furthermore, immunofluorescence analysis of the cross-sectional area of blood vessels clarified that 3-MA could downregulate IL-6 protein expression level ( Figure 5F ), and the increased proinflammatory mediator iNOS protein was inhibited after gene silencing of HDAC4 (Figure 5G) , which further confirmed the fact that gene silencing of HDAC4 ameliorated Ang II-induced vascular inflammation at least partially by mediating autophagy.
FoxO3a is required for Ang II-induced autophagy and HDAC4 controls acetylation of transcription factor FoxO3a
It is reported that Sp-1, a zinc finger protein belonged to the Specificity Factor (Sp) family of transcriptional factors, could mediate HDAC4 expression. 30 To investigate mechanisms that might control expression of HDAC4, we treated cells with mithramycin, a Sp-1 inhibitor. We found that Ang II-induced HDAC4 expression was suppressed by mithramycin in concentration-dependent manner, whilst mithramycin also inhibited the expression of VCAM-1 induced by Ang II ( Figure 6A ). These data suggested that transcriptional factor Sp-1 was involved in Ang II-induced HDAC4 expression in RAECs.
To evaluate whether FoxO3a, a major isoform of the FoxO family, is required for Ang II-induced autophagy, RAECs were transduced with FoxO3a siRNA. Knockdown of FoxO3a decreased LC3-II, Atg5, and Beclin 1 expression in the presence of Ang II, indicating that endogenous FoxO3a is required for Ang II-induced autophagy ( Figure 6B) . FoxO3a acetylation was determined by Western blot with anti-FoxO3a antibody after immunoprecipitation with anti-acetyl-lysine antibody. Treatment of Ang II did not affect protein levels of FoxO3a at various times ( Figure 6C) ; however, FoxO3a acetylation was significantly decreased by Ang II treatment for 48 h ( Figure 6D) . Meanwhile, FoxO3a acetylation of vascular tissues from Ang II-infusion mice was significantly decreased, compared with control mice ( Figure 6D) . Also, we performed Western blot using anti-FoxO3a antibody after immunoprecipitation using anti-acetyl-lysine 
antibody in transfected RAECs with siRNA HDAC4. Results showed that FoxO3a acetylation was increased by HDAC4 knockdown ( Figure 6E) .
As previous studies indicated that FoxO1 acetylation directly disrupts its ability to bind DNA, 31, 32 we examined the association of FoxO3a with autophagy gene promoters. Ang II treatment resulted in increased ChIP of endogenous FoxO3a with the MAP1LC3B (LC3-II) and Atg5 promoters for various time ( Figure 6F) , consistent with increased FoxO3a acetylation and loss of DNA binding.
Discussion
Several reports demonstrated that HDACs are unique and attractive therapeutic targets in clinical research. In this study, we demonstrated that HDAC4 deficiency was associated with a reduced expression of pro-inflammatory markers, which correlated with attenuation of autophagy in Ang II-induced RAECs. In addition, we found that HDAC4 knockdown attenuated cell autophagy in Ang II-stimulated RAECs mainly through up-regulating acetylation-modified FoxO3a to inhibit autophagy. 
Findings provided strong evidence about the uniquely specific function of HDAC4 in eliciting autophagy in response to vascular inflammation, decreased acetylation FoxO3a enhancing DNA-binding activity and association with Atg5 and LC3-II gene promoters to induce the autophagic process, furthermore, the abnormal occurrence of autophagy contributed to the pathological vascular inflammation in Ang II mediatedcardiovascular diseases. It is suggested that HDAC4 might be at least partly responsible for the vascular inflammation in Ang II infusion mice through eliciting autophagic process.
Ang II, the most potent component of the renin-angiotensin system, plays a central role in cardiovascular diseases. 33 Moreover, Ang II mediates the inflammation-associated cardiomyopathy and carotid arterial remodelling, 34 et al. Thus, we used Ang II to induce RAECs inflammation that may provide an approach to make related cardiovascular disorders. HDACs are lysine de-acetylases, which are classified into three main groups based on their homology to yeast proteins, HDAC4 belongs to group II subgroup A of the family. 35 HDACs are emerging as targets for the treatment of several diseases, including cardiac hypertrophy, and heart failure. 36, 37 In this study, we showed that HDAC4 is required for
Ang II-induced inflammation in RAECs and mice, such that inhibition of HDAC4 activity or knockdown of HDAC4 was capable of preventing or reversing pathological vascular inflammation elicited by Ang II. According to literature, transcriptional factor Sp-1 could mediate HDAC4 expression, here, we also determined up-regulated HDAC4 by Ang II through Sp-1 activation. It is been previously reported that HDAC4 mediates vascular inflammation through ROS-dependent NF-jB activation in TNF-a-induced VSMCs. 25 However, the mechanism by which HDAC4 reduction delays Ang II-induced endothelial inflammation is unknown. Thus, further investigation is required to address this issue. Autophagy, a self-digestion and dynamic process, is involved in longlived proteins and dysfunctional organelles degradation. 16, 38 Autophagy maintenance of cellular homeostasis is essential for cell survival, and the altered autophagy has been demonstrated in various pathological alterations. 16 Although the beneficial effects of autophagy in the pathological progression of cardiovascular diseases have been demonstrated by some studies, in some cases, pharmacological inhibition of autophagy after some insults has protective effects. 39, 40 Our data suggested that the autophagic process was over-activated in RAECs and aortic vessels of mice after Ang II treatment. We expected that the over-activated autophagy after Ang II contributes to the pathological progression of vascular inflammation. And, in the present study we found that 3-MA treatment from the 1st day and end on the 4th weeks post Ang II infusion significantly blocked autophagy activation and improved the inflammation alterations in vivo, which further demonstrated this point. 42, 43 Our results suggested that FoxO3a-induced autophagy-related genes including LC3 and Atg5 modulate processes of autophagy. These results were consistent with previous studies that FoxO3 regulated autophagy in skeletal muscle cells by transcriptional activation of genes that were involved in autophagosome formation, including LC3, Atg12l, Atg4, and Beclin1. 41, 44 Perhaps most unexpectedly, the results here suggested that HDAC4 in Ang II treated models actively contributed to the vascular inflammation, which may result from the critical role of FoxO3a in over-activated autophagic process in these vascular inflammation states (see working model in Figure 7) . Remarkably, shRNA-mediated suppression of HDAC4 function led to a dramatic reduction of inflammation response in vivo animal model and in vitro cultured cell model. If extended to human studies, these results suggested that small molecules that inhibit HDAC4 may be useful to vascular inflammation, so the potential utility of HDAC4 inhibitors for the treatment of vascular diseases associated inflammation warrants investigation.
LC3-II, and Atg5; Data are presented as mean ± SEM of four independent experiments; # P < 0.05 (A). VSMCs were transfected with control (si CTL) or HDAC4 small interfering RNA (si HDAC4), then were treated with 2 lM Ang II for 48 h. Expression of HDAC4, Atg5, iNOS, IL-6, and VCAM-1 was determined by Western blotting; Data are presented as mean ± SEM of four independent experiments; # P < 0.05, 
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